Answers are grounded in this paper and cite their sources.
Fluroquinolone antibiotics have been reported to have antiviral properties against RNA viruses, including hepatitis C virus (HCV). In the present study, five patients with advanced liver disease secondary to chronic HCV received 500 mg daily of oral ciprofloxacin for 30 days. Serum HCV-RNA levels and liver enzyme abnormalities remained largely unchanged. Thus, the role of fluoroquinolones as antiviral agents for chronic HCV in patients with advanced liver disease appears to be limited.
No takes yet. Share an insight, caveat, or question.
Kojima et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: